de Lafuente, Y.; Quarta, E.; Magi, M.S.; Apas, A.L.; Pagani, J.; Palena, M.C.; Páez, P.L.; Sonvico, F.; Jimenez-Kairuz, A.F.
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections. Antibiotics 2025, 14, 169.
https://doi.org/10.3390/antibiotics14020169
AMA Style
de Lafuente Y, Quarta E, Magi MS, Apas AL, Pagani J, Palena MC, Páez PL, Sonvico F, Jimenez-Kairuz AF.
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections. Antibiotics. 2025; 14(2):169.
https://doi.org/10.3390/antibiotics14020169
Chicago/Turabian Style
de Lafuente, Yanina, Eride Quarta, MarÃa S. Magi, Ana L. Apas, JoaquÃn Pagani, MarÃa C. Palena, Paulina L. Páez, Fabio Sonvico, and Alvaro F. Jimenez-Kairuz.
2025. "Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections" Antibiotics 14, no. 2: 169.
https://doi.org/10.3390/antibiotics14020169
APA Style
de Lafuente, Y., Quarta, E., Magi, M. S., Apas, A. L., Pagani, J., Palena, M. C., Páez, P. L., Sonvico, F., & Jimenez-Kairuz, A. F.
(2025). Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections. Antibiotics, 14(2), 169.
https://doi.org/10.3390/antibiotics14020169
